BTG3 and metabolic syndrome: Compared with the TAM group, the ANA or LET group had a higher risk of developing abnormal LDL-C levels (no applicable HR for the TAM group without dyslipidemia) and abnormal TC levels (ANA vs. TAM: adjusted HR [95% CI], 5.32 [2.25–12.55], p < 0.001; LET vs. TAM: adjusted HR [95% CI], 3.58 [1.47–8.72], p = 0.005).